Answers are grounded in this paper and cite their sources.
In a large cohort of patients with clinically localized prostate cancer who were managed with one of five primary modalities, the CAPRA score predicted clinical prostate cancer endpoints with good accuracy. These results support the value of the CAPRA score as a risk assessment and stratification tool for both research studies and clinical practice.
No takes yet. Share an insight, caveat, or question.
Cooperberg et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: